Analystreport

NGM Biopharmaceuticals (NYSE: NGM) had its "buy" rating re-affirmed by analysts at Cowen Inc.

NGM Biopharmaceuticals, Inc.  (NGM) 
Last ngm biopharmaceuticals, inc. earnings: 3/17 04:05 pm Check Earnings Report